Potential of RNA Vaccines Beyond COVID

There has been progress in this effort with immunotherapy becoming more common in the treatment of cancer, but many patients don’t respond to the immune boosters being used. Now comes news that patients with lung cancer are surviving twice as long in those who have also been given the mRNA Covid19 vaccines. All to discuss with Professor Luke O Neill , Professor of Biochemistry at the school of Immunology, Trinity College.